Advertising Driven Press Release Distribution
Advertising Driven Press Release Distribution
Desloratadine Market size is forecast to reach 930 million by 2025, growing at a CAGR of 5.81% during the forecast period 2020-2025. Desloratadine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes, sneezing, hives, and itching. An increase in the incidence of allergic rhinitis and nasal congestion are the major factors driving the growth of the market. An increase in the usage of desloratadine in adults and children to relieve hay fever and allergy symptoms is set to further enhance the overall market demand of desloratadine during the forecast period 2020-2025.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501928
Report Price: $ 4500 (Single User License)
Product- Segment Analysis
Desloratadine Injection segment held the largest share in the Desloratadine Market in 2019 and is estimated to grow at a CAGR of 4.06% during the forecast period 2020-2025. This is owing to its usage to inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades. Desloratadine is used to treat allergic rhinitis, nasal congestion, and chronic idiopathic urticaria (hives). It is the major metabolite of loratadine and the two drugs are similar in safety and effectiveness. Many drugs and other substances that are prone to interactions, such as ketoconazole, erythromycin, and grapefruit juice, have shown no influence on desloratadine concentrations in the body. Desloratadine is judged to have a low potential for interactions. Desloratadine Injection is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.
End User- Segment Analysis
The hospital segment held the largest share in the desloratadine market in 2019. Desloratadine is an antihistamine that is used to treat the symptoms of allergies, such as sneezing, watery eyes, itching, and runny nose and is also used to treat skin hives and itching in people with chronic skin reactions. It belongs to a class of drugs called antihistamines and works by blocking the release of a chemical called histamine from the cells in your body. It is used by doctors in the hospital to relieve the symptoms of allergic conditions of patients and it usually starts to work within 75 minutes and lasts for 24 hours. Hospital is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.
Geography – Segment Analysis
North America dominated the desloratadine market in 2019 with a share of more than 38.71%, followed by Europe owing to the increasing number of allergic rhinitis patients. Increasing usage of desloratadine to treat skin hives and itching in people with chronic skin reactions is increasing the growth of the desloratadine market in this region.
However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increasing number of chronic idiopathic urticaria patients. Increasing usage of desloratadine in maintenance therapy or monotherapy is increasing the growth of the desloratadine market in this region.
Talk to one of our sales representative about the full report by providing your details in the link below:
Drivers – Desloratadine Market
An increase in the number of allergic rhinitis and nasal congestion patients is increasing the growth of the desloratadine market. Desloratadine is the orally active metabolite of the nonsedating histamine-1 (H1) receptor antagonist loratadine and is indicated for seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in patients 12 years of age and older. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air and is typically triggered by environmental allergens such as pollen, pet hair, dust, or mold. Inherited genetics and environmental exposures contribute to the development of allergies and it affects the largest number of people. Nasal congestion is the blockage of the nasal passages usually owing to the membranes lining the nose becoming swollen from inflamed blood vessels and it targets the discomfort easily. Thus, increasing the growth of the desloratadine market during the forecast period 2020-2025.
Increasing the incidence of chronic reactions is increasing the growth of the desloratadine market. Desloratadine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes, hives, and itching. It works by blocking a certain natural substance like histamine that the body makes during an allergic reaction. A chronic reaction lasts a long time or occurs often. An allergy occurs when the body’s immune system sees a substance as harmful and overreacts to it. The substances that cause allergic reactions are allergens. Desloratadine has used to alleviate the symptoms of chronic reactions. Thus, increasing the growth of the desloratadine market during the forecast period 2020-2025.
Challenges – Desloratadine Market
Some of the factors that can impede the growth of the desloratadine market are gastrointestinal disturbance and side affects like fatigue and dry mouth.
Desloratadine Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Desloratadine Market. In 2019, Desloratadine Market share is consolidated by the top ten players present in the market. Desloratadine, the top 10 companies are Abbott Laboratory, Apollo Pharmaceuticals, GlaxoSmithKline Plc, Mayne Pharma Inc, Mylan N V, Pfizer Inc, Schering Plough Corporation, Abbot, Takeda Pharmaceutical Company Ltd, and Teva Pharmaceutical Industry Ltd among others.
Intracranial Pressure (ICP) Monitoring Devices Market
About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to firstname.lastname@example.org to discuss more about our consulting services.
Mustard Market Size Forecast to Reach $2.37 Billion by 2026
EPA and DHA Omega-3 PUFA Market Size Estimated to Reach $4.47 Billion by 2025
Acid Descalers Market Forecast to Reach $7 Billion by 2025
Therapeutic Bed Market Poised to Grow at a CAGR of 3.2% over the Forecast Period of 2022-2027
Surface Protection Services Market Estimated to Grow at a CAGR of 5.3% During the Forecast Period 2022-2027